Follow The Filings

SI Shoulder Innovations

Shoulder Innovations earnings company data as of 7:34 PM ET 11/13

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS -0.49 -0.34 Beat
Rev $15.5M $16.2M Beat +4.7%

Insider trades

Open-market buys and sales by SI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SI insider trades
  • $215K bought by 3 insiders
  • $4.6M sold by 2 insiders outside a trading plan
  • $839K sold by 1 insider under 10b5-1 plans
  1. Robert Joseph Ball CEO
    Sale
    $188K 10,175 shares at $18.45 2.6% of stake
    Traded Sep 14 Filed Sep 14
  2. Gilde Healthcare Holding B.V. 10% owner
    Sale
    $27K 1,196 shares at $22.60 0.1% of stake
    Traded Aug 26 Filed Aug 28
  3. Gilde Healthcare Holding B.V. 10% owner
    Sale
    $567K 25,097 shares at $22.61 1.1% of stake
    Traded Aug 20–24 Filed Aug 24
  4. Matthew Fraser Ahearn COO
    Planned sale
    $465K 22,500 shares at $20.66 8.4% of stake
    Traded Aug 17–18 Filed Aug 18
  5. Gilde Healthcare Holding B.V. 10% owner
    Sale
    $213K 9,433 shares at $22.63 0.4% of stake
    Traded Aug 5–6 Filed Aug 7
  6. Gilde Healthcare Holding B.V. 10% owner
    Sale
    $2.5M 110,563 shares at $22.76 4.7% of stake
    Traded Aug 3–4 Filed Aug 5
  7. Gilde Healthcare Holding B.V. 10% owner
    Sale
    $1.1M 48,279 shares at $23.10 2% of stake
    Traded Jul 30–31 Filed Aug 3
  8. Matthew Fraser Ahearn COO
    Planned sale
    $374K 20,000 shares at $18.71 6.9% of stake
    Traded Jun 12–15 Filed Jun 16
  9. Robert Joseph Ball CEO
    Buy
    $33K 2,200 shares at $15.18 +0.8% to stake
    Traded Mar 13 Filed Mar 17
  10. Richard Buchholz Director
    Buy
    $15K 1,000 shares at $14.84 +7.9% to stake
    Traded Mar 13 Filed Mar 17
  11. Jeffrey S. Points CFO
    Buy
    $30K 2,000 shares at $15.00 +2.9% to stake
    Traded Mar 13 Filed Mar 17
  12. Jeffrey S. Points CFO
    Buy
    $30K 2,000 shares at $14.82 +3.8% to stake
    Traded Dec 11–12 Filed Dec 15, 2025
  13. Robert Joseph Ball CEO
    Buy
    $107K 7,200 shares at $14.86 +6.5% to stake
    Traded Dec 11–12 Filed Dec 15, 2025

Also filed in the last 12 months, not counted as buying or selling: 13 stock grants, 10 option exercises, 3 share withholdings for taxes, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
8-K 7.01,9.01
8-K 7.01,9.01
SCHEDULE 13D/A —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 1.01,1.02,2.03,7.01,9.01
8-K 5.07
8-K 2.02,9.01
10-Q
SCHEDULE 13G/A —
DEF 14A
DEFA14A
8-K 7.01,9.01
8-K 1.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf